| scholarly article | Q13442814 |
| P50 | author | Markus Hengstschläger | Q1901560 |
| Georg Krupitza | Q30002284 | ||
| David Sebinger | Q114094537 | ||
| P2093 | author name string | Margit Rosner | |
| Andreas Chott | |||
| Leonhard Müllauer | |||
| Markus Raderer | |||
| Doris Polgar | |||
| Petra Gruber | |||
| Judith Buch | |||
| Sabine Wohlfart | |||
| P2860 | cites work | Identification of paracaspases and metacaspases: two ancient families of caspase-like proteins, one of which plays a key role in MALT lymphoma | Q24290550 |
| NMR structure and mutagenesis of the Fas (APO-1/CD95) death domain | Q27734204 | ||
| The multifaceted role of Fas signaling in immune cell homeostasis and autoimmunity | Q28139188 | ||
| CD95's deadly mission in the immune system | Q28142072 | ||
| Resistance of t(11;18) positive gastric mucosa-associated lymphoid tissue lymphoma to Helicobacter pylori eradication therapy | Q28200343 | ||
| Bcl10 is involved in t(1;14)(p22;q32) of MALT B cell lymphoma and mutated in multiple tumor types | Q28297278 | ||
| The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis | Q29618601 | ||
| Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis | Q30080034 | ||
| Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity | Q33488225 | ||
| The molecular basis for apoptotic defects in patients with CD95 (Fas/Apo-1) mutations | Q33836041 | ||
| The apoptosis inhibitor gene API2 and a novel 18q gene, MLT, are recurrently rearranged in the t(11;18)(q21;q21) associated with mucosa-associated lymphoid tissue lymphomas | Q33862984 | ||
| Activation of apoptosis pathways by anticancer treatment. | Q33864763 | ||
| The gastric marginal zone B-cell lymphoma of MALT type. | Q33962393 | ||
| Gastric MALT lymphoma: from aetiology to treatment | Q34569977 | ||
| The origin of CD95-gene mutations in B-cell lymphoma | Q34584971 | ||
| A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor | Q34661010 | ||
| Relationship between high-grade lymphoma and low-grade B-cell mucosa-associated lymphoid tissue lymphoma (MALToma) of the stomach | Q35811228 | ||
| Autocrine T-cell suicide mediated by APO-1/(Fas/CD95) | Q41371079 | ||
| A novel protein domain required for apoptosis. Mutational analysis of human Fas antigen | Q41553101 | ||
| The product of the t(11;18), an API2-MLT fusion, marks nearly half of gastric MALT type lymphomas without large cell proliferation | Q42074394 | ||
| Complete remission of primary high-grade B-cell gastric lymphoma after cure of Helicobacter pylori infection | Q43562732 | ||
| Prospective study of Helicobacter pylori eradication therapy in stage I(E) high-grade mucosa-associated lymphoid tissue lymphoma of the stomach | Q43800133 | ||
| CD95 (Fas)-dependent elimination of self-reactive B cells upon interaction with CD4+T cells | Q45971909 | ||
| Inactivation of the Fas gene by Alu insertion: retrotransposition in an intron causing splicing variation and autoimmune lymphoproliferative syndrome. | Q48284203 | ||
| Fas is required for clonal selection in germinal centers and the subsequent establishment of the memory B cell repertoire | Q48377105 | ||
| Loss of Fas (CD95/APO-1) regulatory function is an important step in early MALT-type lymphoma development | Q49240035 | ||
| Somatic Fas mutations in non-Hodgkin's lymphoma: association with extranodal disease and autoimmunity. | Q52532296 | ||
| Lack of CD95/FAS gene somatic mutations in extranodal, nodal and splenic marginal zone B cell lymphomas. | Q53412361 | ||
| Frequent mutations of Fas gene in thyroid lymphoma. | Q53895930 | ||
| Tumor B cells from non-Hodgkin's lymphoma are resistant to CD95 (Fas/Apo-1)-mediated apoptosis. | Q54138930 | ||
| Variable frequencies of t(11;18)(q21;q21) in MALT lymphomas of different sites: significant association with CagA strains of H pylori in gastric MALT lymphoma. | Q54780176 | ||
| MALT1 is deregulated by both chromosomal translocation and amplification in B-cell non-Hodgkin lymphoma. | Q54792360 | ||
| Monoclonal antibody-mediated tumor regression by induction of apoptosis. | Q55059937 | ||
| Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome | Q55670225 | ||
| Involvement of the CD95 (APO–1/Fas) receptor/ligand system in drug–induced apoptosis in leukemia cells | Q57384660 | ||
| Identification and characterisation of polymorphisms in the promoter region of the human Apo-1/Fas (CD95) gene | Q61863688 | ||
| Cytogenetic study of B-cell lymphoma of mucosa-associated lymphoid tissue | Q67722602 | ||
| Gastrointestinal malignant lymphomas of the mucosa-associated lymphoid tissue: factors relevant to prognosis | Q68100709 | ||
| The accumulation of p53 abnormalities is associated with progression of mucosa-associated lymphoid tissue lymphoma | Q70837491 | ||
| Detection of polymorphisms within the Fas cDNA gene sequence by GC-clamp denaturing gradient gel electrophoresis | Q71624184 | ||
| Targeted mutation in the Fas gene causes hyperplasia in peripheral lymphoid organs and liver | Q71794021 | ||
| The t(11;18)(q21;q21) chromosome translocation is a frequent and specific aberration in low-grade but not high-grade malignant non-Hodgkin's lymphomas of the mucosa-associated lymphoid tissue (MALT-) type | Q73722532 | ||
| BCL10 gene mutation in lymphoma | Q73877021 | ||
| T(14;18)(q32;q21) involving IGH and MALT1 is a frequent chromosomal aberration in MALT lymphoma | Q78447749 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | MALT lymphoma | Q591256 |
| diffuse large B-cell lymphoma | Q2626074 | ||
| gastric diffuse large B-cell lymphoma | Q55780047 | ||
| P304 | page(s) | 1081-9 | |
| P577 | publication date | 2004-03-01 | |
| P1433 | published in | The American Journal of Pathology | Q4744259 |
| P1476 | title | FAS (CD95) mutations are rare in gastric MALT lymphoma but occur more frequently in primary gastric diffuse large B-cell lymphoma | |
| P478 | volume | 164 |
| Q37951369 | CD95-mediated cell signaling in cancer: mutations and post-translational modulations |
| Q36297659 | Clinical significance of standardized uptake value and maximum tumor diameter in patients with primary extranodal diffuse large B cell lymphoma |
| Q38261966 | Crosstalk between CTC, Immune System and Hypoxic Tumor Microenvironment |
| Q46434131 | Downregulation of Fas gene expression in Sézary syndrome is associated with promoter hypermethylation |
| Q80543254 | Fas/Fas ligand gene polymorphism in patients with papillary thyroid cancer in the Turkish population |
| Q36005932 | Gastrointestinal lymphoma: where morphology meets molecular biology |
| Q35974341 | Genetic lesions in diffuse large B-cell lymphomas |
| Q52647877 | High-throughput sequencing of nodal marginal zone lymphomas identifies recurrent BRAF mutations. |
| Q43276971 | Identification, characterisation and regulation by CD40 activation of novel CD95 splice variants in CD95-apoptosis-resistant, human, B-cell non-Hodgkin's lymphoma. |
| Q34579196 | Immune surveillance of tumors |
| Q36814969 | Mutations within the 5' region of FAS/CD95 gene in nodal diffuse large B-cell lymphoma |
| Q39578363 | Over-expressed Fas improves the apoptosis of malignant T-cells in vitro and vivo |
| Q51574456 | Prognostic significance of CD95, P53, and BCL2 expression in extranodal non-Hodgkin's lymphoma. |
| Q53116215 | Prognostic value of Waldeyer's ring involvement of diffuse large B-cell lymphoma treated with R-CHOP. |
| Q46961792 | Ras mediates cell survival by regulating tuberin |
| Q53622635 | Tuberin activates the proapoptotic molecule BAD. |
Search more.